ClinVar Miner

Submissions for variant NM_000053.4(ATP7B):c.1470C>A (p.Cys490Ter)

dbSNP: rs778675259
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000411554 SCV000485590 likely pathogenic Wilson disease 2016-01-14 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000411554 SCV000918608 pathogenic Wilson disease 2018-12-10 criteria provided, single submitter clinical testing Variant summary: ATP7B c.1470C>A (p.Cys490X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg. p.Gln511X, p.Ile582fsX25, p.Gln717X). The variant was absent in 246092 control chromosomes. c.1470C>A has been reported in the literature in multiple individuals affected with Wilson Disease (Tsai_1999, Cheng_2017). These data indicate that the variant is very likely to be associated with disease. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Genome-Nilou Lab RCV000411554 SCV001977376 likely pathogenic Wilson disease 2021-08-10 criteria provided, single submitter clinical testing
Invitae RCV000411554 SCV002131855 pathogenic Wilson disease 2022-08-05 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 370319). This premature translational stop signal has been observed in individual(s) with ATP7B-related conditions (PMID: 9829905, 30366773). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Cys490*) in the ATP7B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATP7B are known to be pathogenic (PMID: 10441329, 16283883).
Fulgent Genetics, Fulgent Genetics RCV000411554 SCV002803376 pathogenic Wilson disease 2021-08-06 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.